ESMO Congress 2024 GU Round-Up: Bladder Cancer

At the ESMO Congress 2024, Karine Tawagi, MD, of University of Illinois, and Christopher Wallis, MD, PhD, of University of Toronto, provide an overview of some of the most relevant research updates from the meeting in urothelial carcinoma.

The SunRISe-1 and AMBASSADOR trials are the focus of heir conversation.